Jess F. Gamble

1.7k total citations · 1 hit paper
21 papers, 1.3k citations indexed

About

Jess F. Gamble is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Jess F. Gamble has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 8 papers in Oncology. Recurrent topics in Jess F. Gamble's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (6 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Jess F. Gamble is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (6 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Jess F. Gamble collaborates with scholars based in United States. Jess F. Gamble's co-authors include Lillian M. Fuller, C. C. Shullenberger, Charles A. Coltman, Henry E. Wilson, Eugene M. McKelvey, Jeffrey A. Gottlieb, Stephen E. Jones, P Grozea, Ronald L. Stephens and Thomas E. Moon and has published in prestigious journals such as Annals of Internal Medicine, Cancer and Radiology.

In The Last Decade

Jess F. Gamble

21 papers receiving 1.2k citations

Hit Papers

Hydroxyldaunomycin (adriamycin) combination chemotherapy ... 1976 2026 1992 2009 1976 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jess F. Gamble United States 16 1.0k 587 340 316 315 21 1.3k
A.M. Jelliffe United Kingdom 18 1.3k 1.2× 751 1.3× 522 1.5× 391 1.2× 247 0.8× 54 1.8k
Patrizio Mazza Italy 22 1.1k 1.0× 680 1.2× 516 1.5× 248 0.8× 387 1.2× 98 1.8k
Alejandra Talavera Mexico 16 555 0.5× 503 0.9× 140 0.4× 116 0.4× 155 0.5× 50 867
R. E. Marcus United Kingdom 18 1.1k 1.1× 979 1.7× 640 1.9× 156 0.5× 223 0.7× 47 1.9k
B. W. Hancock United Kingdom 16 434 0.4× 487 0.8× 203 0.6× 148 0.5× 111 0.4× 52 1.3k
J. Jaubert France 15 829 0.8× 346 0.6× 879 2.6× 173 0.5× 97 0.3× 46 1.7k
Canellos Gp United States 20 477 0.5× 361 0.6× 412 1.2× 160 0.5× 84 0.3× 49 1.3k
Stephen J. Proctor United Kingdom 24 713 0.7× 388 0.7× 401 1.2× 167 0.5× 153 0.5× 49 1.8k
A. Z. S. Rohatiner United Kingdom 15 923 0.9× 575 1.0× 313 0.9× 268 0.8× 126 0.4× 41 1.4k
Rika Sakai Japan 24 581 0.6× 526 0.9× 370 1.1× 147 0.5× 196 0.6× 107 1.5k

Countries citing papers authored by Jess F. Gamble

Since Specialization
Citations

This map shows the geographic impact of Jess F. Gamble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jess F. Gamble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jess F. Gamble more than expected).

Fields of papers citing papers by Jess F. Gamble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jess F. Gamble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jess F. Gamble. The network helps show where Jess F. Gamble may publish in the future.

Co-authorship network of co-authors of Jess F. Gamble

This figure shows the co-authorship network connecting the top 25 collaborators of Jess F. Gamble. A scholar is included among the top collaborators of Jess F. Gamble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jess F. Gamble. Jess F. Gamble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gamble, Jess F., et al.. (1980). Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease. Cancer. 46(11). 2349–2355. 16 indexed citations
2.
Fuller, Lillian M., Jess F. Gamble, James J. Butler, et al.. (1980). Evaluation of the significance of prognostic factors in stage III Hodgkin's disease treated with MOPP and radiotherapy. Cancer. 45(6). 1352–1364. 24 indexed citations
3.
Fuller, Lillian M., Hywel Madoc‐Jones, Frederick Hagemeister, et al.. (1980). Further follow-up of results of treatment in 90 laparotomy-negative stage I and II Hodgkin's disease patients: Significance of mediastinal and non-mediastinal presentations. International Journal of Radiation Oncology*Biology*Physics. 6(7). 799–808. 58 indexed citations
4.
Toonkel, Leonard M., Lillian M. Fuller, Jess F. Gamble, et al.. (1980). Laparotomy staged I and II non-Hodgkin's lymphomas preliminary results of radiotherapy and adjunctive chemotherapy. Cancer. 45(2). 249–260. 36 indexed citations
5.
Fuller, Lillian M., Richard G. Martin, James J. Butler, et al.. (1980). Laparotomy findings in lymphangiogram-staged I and II non-Hodgkin's lymphomas. Cancer. 45(11). 2778–2786. 30 indexed citations
6.
Fuller, Lillian M., Jess F. Gamble, J. G. Sinkovics, et al.. (1977). Team approach to management of non-Hodgkin's lymphomas: past and present.. PubMed. 61(6). 1137–48. 7 indexed citations
7.
Fuller, Lillian M., Hywel Madoc‐Jones, Jess F. Gamble, et al.. (1977). New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients. Cancer. 39(5). 2174–2182. 41 indexed citations
8.
Ali, Mohsin, Kamal Khalil, Lillian M. Fuller, et al.. (1976). Radiation-related myocardial injury.Management of Two Cases. Cancer. 38(5). 1941–1946. 47 indexed citations
9.
McKelvey, Eugene M., Jeffrey A. Gottlieb, Henry E. Wilson, et al.. (1976). Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer. 38(4). 1484–1493. 625 indexed citations breakdown →
10.
Gamble, Jess F., Lillian M. Fuller, Richard G. Martin, et al.. (1975). Influence of staging celiotomy in localized presentations of Hodgkin's disease. Cancer. 35(3). 817–825. 20 indexed citations
11.
Ayala, Alberto G., et al.. (1975). Eosinophilic Meningitis and Lymphomatous Meningitis. Annals of Internal Medicine. 82(2). 228–228. 16 indexed citations
12.
Fuller, Lillian M., et al.. (1973). Stage II Hodgkin's Disease. Radiology. 109(2). 429–435. 27 indexed citations
13.
Gamble, Jess F.. (1973). Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease. Archives of Internal Medicine. 131(3). 435–438. 8 indexed citations
14.
Tessmer, Carl F., et al.. (1973). Significance of serum copper levels in adult patients with Hodgkin's disease. Cancer. 31(6). 1337–1345. 66 indexed citations
15.
Tessmer, Carl F., et al.. (1973). Serum copper observations in patients with malignant lymphoma. Cancer. 32(6). 1512–1524. 55 indexed citations
16.
Gamble, Jess F.. (1973). Combined Chemotherapy. Archives of Internal Medicine. 131(3). 435–435. 9 indexed citations
17.
Fuller, Lillian M., et al.. (1972). Stage I Hodgkin's Disease. Radiology. 104(1). 145–151. 12 indexed citations
18.
Fuller, Lillian M., Jess F. Gamble, C. C. Shullenberger, James J. Butler, & Edmund A. Gehan. (1971). Prognostic Factors in Localized Hodgkin's Disease Treated with Regional Radiation. Radiology. 98(3). 641–654. 40 indexed citations
19.
Luce, James K., Jess F. Gamble, Henry E. Wilson, et al.. (1971). Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma. Cancer. 28(2). 306–317. 162 indexed citations
20.
Frei, Emil & Jess F. Gamble. (1966). Progress in the chemotherapy of Hodgkin's disease. Cancer. 19(3). 378–384. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026